Tackling Biological Risk in the Workplace: Updates and Prospects Regarding Vaccinations for Subjects at Risk of Occupational Exposure in Italy.

occupational biological risk occupational medicine preventive and protective measures vaccinations workplace

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
08 Oct 2019
Historique:
received: 20 09 2019
accepted: 23 09 2019
entrez: 11 10 2019
pubmed: 11 10 2019
medline: 11 10 2019
Statut: epublish

Résumé

Occupational activities may expose workers to a variety of risks. Exposure to biological agents constitutes a traditional risk in numerous occupational settings. Legislative Decree (D.Lgs.) 81/2008 constitutes the main Italian legislative basis for the management and the prevention of biological risk in occupational settings and lists the available vaccinations against each single biological agent. The 2017-2019 National Vaccination Prevention Plan (PNPV) identifies some categories of workers for whom specific vaccinations are indicated. In this context, the occupational physician identifies work processes that are at risk-identifying susceptible workers and providing information on health monitoring-and is responsible for ensuring that vaccinations are carried out. Adequate and thorough evaluation of risk are indispensable to appropriate consultation by the occupational physician in order to enable the employer to provide efficacious vaccinations. Close collaboration among the services of occupational medicine, vaccination clinics, and healthcare management together with the implementation of vaccination programs that are agreed upon at the institutional level provides an opportunity to reduce the number of workers who are susceptible to vaccine-preventable diseases, thereby yielding benefits in terms of biological risk management in the workplace and contributing to increasing vaccination coverage rates, which in many cases are currently unsatisfactory.

Identifiants

pubmed: 31597371
pii: vaccines7040141
doi: 10.3390/vaccines7040141
pmc: PMC6963441
pii:
doi:

Types de publication

Editorial

Langues

eng

Déclaration de conflit d'intérêts

P. Durando received funds for sponsorized clinical trials and get involved in Advisory boards from GSK, Novartis, Pfizer and Sanofi Pasteur in the last 5 years.

Références

Ind Health. 2012;50(4):326-37
pubmed: 22785422
Euro Surveill. 2017 Sep 14;22(37):
pubmed: 28933342
J Prev Med Hyg. 2018 Mar 30;59(1):E8-E13
pubmed: 29938234
J Prev Med Hyg. 2019 Mar 29;60(1):E12-E17
pubmed: 31041405

Auteurs

Paolo Durando (P)

Section of Occupational Medicine, Department of Health Sciences, University of Genoa, Via A. Pastore 1, 16132 Genoa, Italy. durando@unige.it.
Occupational Medicine Unit, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi, 10 (Building 3), 16132 Genoa, Italy. durando@unige.it.

Guglielmo Dini (G)

Section of Occupational Medicine, Department of Health Sciences, University of Genoa, Via A. Pastore 1, 16132 Genoa, Italy. guglielmo.dini@unige.it.
Occupational Medicine Unit, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi, 10 (Building 3), 16132 Genoa, Italy. guglielmo.dini@unige.it.

Emanuela Massa (E)

Section of Occupational Medicine, Department of Health Sciences, University of Genoa, Via A. Pastore 1, 16132 Genoa, Italy. emanuela.massa@edu.unige.it.

Giuseppe La Torre (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy. giuseppe.latorre@uniroma1.it.
Occupational Medicine Unit, Policlinico Umberto I Hospital, Viale del Policlinico 155, 00185 Rome, Italy. giuseppe.latorre@uniroma1.it.

Classifications MeSH